Skip to main content
. 1999 Jan 19;96(2):680–685. doi: 10.1073/pnas.96.2.680

Table 1.

Patient characteristics

Patient Age, months Sex WBC, × 103/μl HSM Immunophenotype Karyotype MLL-AF4 fusion transcript
INF-1 2 F 6 B 46,XX,t(4;11)(q21;q23)[12]/46,XX[8] +
INF-2 4 F 346 + B 46,XX,t(4;11)(q21;q23)[10] +
INF-3 3 F 285 + B Not determined +
INF-4 1 F 410 + B Not determined +
INF-5 8 M 1,000 + B 46,XY,t(4;11)(q21;q23),t(14;19)(q11.2;p13)[12]/46,XY[8] +
INF-6 2 F 670 + B 46,XX,t(4;11)(q21;q23)[20] +
INF-7 3 F 684 + B 46,XX,t(4;11)(q21;q23)[17]/46,XX[3] +
INF-8 9 F 41 + B 46,XX[29] +
INF-9 2 M 187 + B 46,XY,t(4;11)(q21;q23)[16]/46,XY[6] +
INF-10 5 M 317 + B Not determined +
INF-11 2 M 270 + B 46,XX,t(11;19)(q23;p13)[20]
INF-12 6 M 83 B Not determined

MLL-AF4 fusion transcript expression was determined by RT-PCR. HSM, hepatosplenomegaly; WBC, white blood cells; INF, infant; M, male; F, female; B, B-lineage.